Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7764)
All Articles published online
|
Publishing Process of This Article
|
Mar 24, 2020 (publication date) through Nov 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rahardja S, Tan RYC, Sultana R, Leong FL, Lim EH. Efficacy, patterns of use and cost of Pertuzumab in the treatment of HER2+ metastatic breast cancer in Singapore: The National Cancer Centre Singapore experience. World J Clin Oncol 2020; 11(3): 143-151 [PMID: 32257845 DOI: 10.5306/wjco.v11.i3.143] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v11/i3/143.htm |
| Number | Citing Articles |
| 1 |
Wei Fang Dai, Jaclyn M. Beca, Chenthila Nagamuthu, Ning Liu, Claire de Oliveira, Craig C. Earle, Maureen Trudeau, Rebecca E. Mercer, Kelvin K. W. Chan. Comparative Effectiveness and Safety of Pertuzumab and Trastuzumab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy for Treatment of Metastatic Breast Cancer. JAMA Network Open 2022; 5(2): e2145460 doi: 10.1001/jamanetworkopen.2021.45460
|
| 2 |
Silvia Falcon, Luis Riva, Christina Flores, Delphis Vera, Joseph Pinto, Henry Gomez. Neoadjuvant pertuzumab in non‑metastatic HER2‑positive breast tumors: Multicentric study in Peru (NeoHer). Molecular and Clinical Oncology 2022; 16(3) doi: 10.3892/mco.2022.2503
|
| 3 |
Sreeram V. Ramagopalan, Riccardo Pisoni, Lokendra Singh Rathore, Joshua Ray, Cormac Sammon. Association of Pertuzumab, Trastuzumab, and Docetaxel Combination Therapy With Overall Survival in Patients With Metastatic Breast Cancer. JAMA Network Open 2021; 4(1): e2027764 doi: 10.1001/jamanetworkopen.2020.27764
|